Related Experiment Video
Updated: Aug 25, 2026
Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Reduction of Smad3 accelerates re-epithelialization in a murine model of colitis
Atsuko Tokumasa1, Tatsuro Katsuno, Tsunemi S Tanaga
1Clinical Cell Biology (F5), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ward, Chiba-City 260-8670, Japan.
Abstract:
To determine the role of Smad3 in re-epithelialization and inflammation, experimental colitis was induced in Smad3 heterozygous mice and their wild-type littermates by single intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) in ethanol. The area of epithelial deficiency was significantly reduced in the heterozygotes on the 4th-6th day after TNBS administration as compared to the controls although the number of inflammatory cells in the colonic mucosa in the heterozygotes and their wild-type littermates varied similarly throughout the course of colitis. Proliferation of the intestinal epithelium in the heterozygotes was significantly accelerated as compared to that in the wild-type controls on the 1st and 2nd days after TNBS administration. These results suggest that reduction of Smad3 significantly accelerates re-epithelialization of the intestinal mucosa without enhancing inflammation. Suppression of TGF-beta1 induction in the colonic mucosa of the heterozygotes may lead to a higher level of proliferation of intestinal epithelial cells.
Insights
Reduced Smad3 accelerates intestinal repair in colitis models without increasing inflammation. This suggests Smad3 plays a key role in regulating epithelial healing and inflammatory responses in the gut.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Smad3 is a key mediator of TGF-beta signaling.
- TGF-beta signaling influences epithelial repair and inflammation.
Purpose of the Study:
- To investigate the role of Smad3 in re-epithelialization and inflammation during experimental colitis.
- To assess the impact of reduced Smad3 on intestinal epithelial cell proliferation and inflammatory cell infiltration.
Main Methods:
- Experimental colitis was induced in Smad3 heterozygous and wild-type mice using 2,4,6-trinitrobenzene sulfonic acid (TNBS).
- Epithelial deficiency, inflammatory cell counts, and epithelial proliferation were assessed at various time points post-induction.
Main Results:
- Heterozygous mice showed significantly reduced epithelial deficiency, indicating accelerated re-epithelialization.
- Intestinal epithelial proliferation was significantly accelerated in heterozygotes on days 1-2 post-TNBS.
- Inflammatory cell infiltration patterns were similar between heterozygotes and wild-type littermates.
Conclusions:
- Reduction of Smad3 significantly accelerates intestinal mucosa re-epithelialization without exacerbating inflammation.
- Suppressed TGF-beta1 induction in Smad3 heterozygotes may contribute to enhanced intestinal epithelial cell proliferation.
- Smad3 is a critical regulator of intestinal healing in colitis.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014